3 US Dividend Stocks Worth Watching While Rates Stay Higher

Higher rates are back in the spotlight. The Fed has lifted its key benchmark to a range of 3.75 to 4.00% and signaled that borrowing costs could stay elevated for longer, which puts a new kind of pressure on both borrowers and cash-rich dividend stocks. That shift creates a potential opening for investors who care about income, value and resilience. This article walks through three large-cap dividend stocks from our screener that appear meaningfully exposed to this rate shock, and why their reaction to this moment deserves attention.

The three dividend payers in focus below are only a starting sample, and the full screen surfaced 35 more large caps with equally compelling income and value stories that are not covered here. To size up the wider field, identify higher conviction ideas, and pressure test your own watchlist, go straight to the US Large-Cap Value and Dividend Stocks screener.

Elevance Health (ELV)

Overview: Elevance Health is a large U.S. health benefits provider offering medical, pharmacy, behavioral, and care management services across commercial and government programs.

Operations: Elevance Health generates about US$169.3b from Health Benefits and US$74.2b from Carelon pharmacy and services, almost entirely in the United States.

Market Cap: US$88.8b

Elevance Health fits this large cap dividend and value screen as a cash generative insurer that can matter when borrowing costs climb and investors look for durable income tied to everyday healthcare spending.

Ongoing deployment of Elevance Health’s AI, analytics and digital platforms such as HealthOS and Sydney Health, including automated prior authorization and earlier visibility into medical cost trends, is expected to tighten medical cost management and support more stable net margins and earnings over time.

The real swing factor is how one stubborn pocket of medical cost pressure behaves if pricing and care programs do not fully keep pace.

If that pressure point is what you care about, read the full narrative for Elevance Health to see how Elevance Health could keep earnings and dividends decoupling from rate shocks.

Otter Tail (OTTR)

Overview: Otter Tail is a regulated electric utility with manufacturing and plastics operations that provide diversified, dividend-paying cash flows across U.S. end markets.

Operations: Otter Tail generates about US$575 million from Electric, US$407 million from Plastics, and US$332 million from Manufacturing activities.

Market Cap: US$3.7b

Otter Tail fits this large cap value and dividend screen as a regulated utility with a higher-yield profile that can appeal when investors seek steadier income while rates stay elevated.

"The anticipated phaseout of renewable energy credits and new restrictions under recent federal legislation threaten the economics of Otter Tail's future renewable projects beyond its currently secured solar and wind investments. This could potentially raise capital requirements and pressure future earnings growth by reducing the after-tax returns on major rate base expansions."

What happens if a single assumption about long term project economics breaks could make a real difference to margins and dividend comfort.

If that risk proves manageable for Otter Tail, the full narrative for Otter Tail illustrates how regulation, diversification and capital discipline could continue to support its dividend story.

LKQ (LKQ)

Overview: LKQ distributes replacement auto parts and accessories for vehicle repair and maintenance, offering a dividend-paying value profile in higher-rate periods.

Operations: LKQ generates about US$6.3b from Europe and US$5.7b from North America, with smaller Specialty and elimination adjustments.

Market Cap: US$5.9b

LKQ matters in this dividend and value list because it taps into everyday vehicle repair spending. This can behave differently to high-growth stories when borrowing costs climb and investors want cash flow that ties to ongoing car usage.

"Growth in miles driven increases the wear and tear on vehicles, requiring more maintenance and repair work to keep them on the road, benefiting LKQ.

What could really shape that income profile is how one quiet pressure on its repair volumes and pricing power resolves over time.

That quiet pressure point is exactly where LKQ’s story gets interesting, and the full narrative for LKQ shows how repair demand and pricing power could still accelerate.

Seeking Alternatives Before Momentum Flies

Fresh ideas move first. By the time every investor piles in, the best entry points can be gone. Scan these under the radar for now, then act now.

• Chase income that does more of the heavy lifting with a curated set of high yield payers in the 7 dividend fortresses before those payouts get fully priced in.
• Spot early leaders in automation and factory efficiency by tracking companies inside the 95 robotics and automation stocks while the next leg of industrial spending is still building.
• Position ahead of infrastructure upgrades by reviewing power suppliers and grid enablers through the 40 power grid technology and infrastructure stocks while these stories remain underowned.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com